Taken together, these data suggest that the increase in FOXP3+ Tregs among CD4+ T cells in patients with TS is a compensatory response to suppress activated and inflammatory cytokine-producing effector CD4+ T cell responses. The gene discussed is FOXP3; the disease is Timothy syndrome.